Gilead Sciences commences HIV drug trial
GS-7340 is a nucleotide reverse transcriptase inhibitor (NtRTI) similar to the company’s HIV drug Viread. The double-blind 48-week clinical trial will include150 patients, who are randomized (2:1) to
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.
NextDocs’solutions can ensure users the consistency of workflow processes and document handling, with the capability of re-engineering business processes using workflow controls if necessary. In addition, NextDocs’ collection